Suchergebnisse - "Caro, Luzelena"

PubPharm (79)

1

Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients

enthalten in: The Pediatric infectious disease journal | 2024

von Groll, A. | Schulte, J. | Antmen, A. | +9

2

Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Phuah, J. | Maas, B. | Tang, A. | +10

3

Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV

enthalten in: AIDS (London, England) | 2023

von Sterman, F. | Lalezari, J. | Kowalczyk, U. | +5

CommentIn: AIDS. 2023 Jun 1;37(7):1165-1166. - PMID 37139652

4

Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection : a pharmacokinetic modeling study

enthalten in: Hepatology communications | 2023

von Gonzalez-Peralta, R. | Wirth, S. | Squires, R. | +18

5

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults

enthalten in: Clinical and translational science | 2022

von Orito, Y. | Otani, N. | Matsumoto, Y. | +11

6

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK‐1654 in healthy Japanese adults

enthalten in: Clinical and Translational Science | 2022

von Orito, Y. | Otani, N. | Matsumoto, Y. | +11

7

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

enthalten in: EBioMedicine | 2021

von Maas, B. | Lommerse, J. | Plock, N. | +25

8

Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program

enthalten in: Clinical pharmacology and therapeutics | 2021

von Galluppi, G. | Brar, S. | Caro, L. | +17

9

Immune-viral dynamics modeling for SARS-CoV-2 drug development

enthalten in: Clinical and translational science | 2021

von Cao, Y. | Gao, W. | Caro, L. | +1

10

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy Adults

enthalten in: Clinical pharmacology in drug development | 2021

von Aliprantis, A. | Wolford, D. | Caro, L. | +12

1
2
3
4
5
6
7
8
Nächster »
[8]